Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Measurement properties of walking outcome measures for neurogenic claudication: a systematic review and meta analysis.

Anderson DB, Mathieson S, Eyles J, Maher CG, Van Gelder JM, Tomkins-Lane CC, Ammendolia C, Bella V, Ferreira ML.

Spine J. 2019 Aug;19(8):1378-1396. doi: 10.1016/j.spinee.2019.04.004. Epub 2019 Apr 12. Review.

PMID:
30986579
2.

Effectiveness of Self-guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Clinical Trial.

Donker T, Cornelisz I, van Klaveren C, van Straten A, Carlbring P, Cuijpers P, van Gelder JL.

JAMA Psychiatry. 2019 Jul 1;76(7):682-690. doi: 10.1001/jamapsychiatry.2019.0219.

PMID:
30892564
3.

CLASH's life history foundations.

Frankenhuis WE, Fenneman J, van Gelder JL, Godoy I.

Behav Brain Sci. 2017 Jan;40:e84. doi: 10.1017/S0140525X16001011.

PMID:
29342544
4.

Cyber-Offending and Traditional Offending over the Life-Course: an Empirical Comparison.

Weulen Kranenbarg M, Ruiter S, van Gelder JL, Bernasco W.

J Dev Life Course Criminol. 2018;4(3):343-364. doi: 10.1007/s40865-018-0087-8. Epub 2018 Aug 1.

5.

Vividness of the future self predicts delinquency.

van Gelder JL, Hershfield HE, Nordgren LF.

Psychol Sci. 2013 Jun;24(6):974-80. doi: 10.1177/0956797612465197. Epub 2013 Apr 16.

PMID:
23592649
6.

Developability assessment of clinical drug products with maximum absorbable doses.

Ding X, Rose JP, Van Gelder J.

Int J Pharm. 2012 May 10;427(2):260-9. doi: 10.1016/j.ijpharm.2012.02.003. Epub 2012 Feb 13.

PMID:
22349050
7.

Is postoperative intensive care unit admission a prerequisite for elective craniotomy?

Bui JQ, Mendis RL, van Gelder JM, Sheridan MM, Wright KM, Jaeger M.

J Neurosurg. 2011 Dec;115(6):1236-41. doi: 10.3171/2011.8.JNS11105. Epub 2011 Sep 2.

PMID:
21888476
8.

Long-term results of the posteromedial release in the treatment of idiopathic clubfoot.

van Gelder JH, van Ruiten AG, Visser JD, Maathuis PG.

J Pediatr Orthop. 2010 Oct-Nov;30(7):700-4. doi: 10.1097/BPO.0b013e3181ec9402.

PMID:
20864856
9.
10.

Meta-analysis and use of tests of heterogeneity in neurosurgery.

Cheong JY, Van Gelder JM.

J Clin Neurosci. 2010 Feb;17(2):163-7. doi: 10.1016/j.jocn.2009.04.025. Epub 2010 Jan 6. Review.

PMID:
20056420
11.

Long-term reliability of endoscopic third ventriculostomy.

Kadrian D, van Gelder J, Florida D, Jones R, Vonau M, Teo C, Stening W, Kwok B.

Neurosurgery. 2008 Feb;62 Suppl 2:614-21. doi: 10.1227/01.neu.0000316265.59596.8c.

PMID:
18596443
12.

Colloid cyst of the third ventricle in opposite sex, non-twin siblings.

van Gelder JM, Dahlstrom JE, Newcombe RL.

J Clin Neurosci. 1998 Apr;5(2):207-9.

PMID:
18639013
13.

A general approach to the apparent permeability index.

Palumbo P, Picchini U, Beck B, van Gelder J, Delbar N, DeGaetano A.

J Pharmacokinet Pharmacodyn. 2008 Apr;35(2):235-48. doi: 10.1007/s10928-008-9086-4. Epub 2008 Mar 20.

PMID:
18351296
14.

Helodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicle-associated epithelium.

des Rieux A, Fievez V, Momtaz M, Detrembleur C, Alonso-Sande M, Van Gelder J, Cauvin A, Schneider YJ, Préat V.

J Control Release. 2007 Apr 23;118(3):294-302. Epub 2006 Dec 29.

15.
16.

Letter to the editor.

van Gelder JM.

J Clin Neurosci. 2006 Feb;13(2):304-5; author reply 306. Epub 2006 Feb 2. No abstract available.

PMID:
16458006
17.

Long-term reliability of endoscopic third ventriculostomy.

Kadrian D, van Gelder J, Florida D, Jones R, Vonau M, Teo C, Stening W, Kwok B.

Neurosurgery. 2005 Jun;56(6):1271-8; discussion 1278.

PMID:
15918943
18.

Association between compensation status and outcome after surgery: a meta-analysis.

Harris I, Mulford J, Solomon M, van Gelder JM, Young J.

JAMA. 2005 Apr 6;293(13):1644-52. Review.

PMID:
15811984
19.

A probabilistic and interactive decision-analysis system for unruptured intracranial aneurysms.

Ghinea N, van Gelder JM.

Neurosurg Focus. 2004 Nov 15;17(5):E9.

PMID:
15633986
20.

Estimating the annual rate of de novo multiple aneurysms: three statistical approaches.

Cheong JJ, Ghinea N, van Gelder JM.

Neurosurg Focus. 2004 Nov 15;17(5):E8.

PMID:
15633985
22.

Clinical experience with the low pressure Novus valve in the treatment of adult hydrocephalus.

Chong CC, van Gelder J, Sheridan M.

J Clin Neurosci. 2002 Sep;9(5):539-43.

PMID:
12383411
23.

The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis.

Huang J, van Gelder JM.

Neurosurgery. 2002 Nov;51(5):1101-5; discussion 1105-7.

PMID:
12383354
24.

Inhibitory effect of fruit extracts on P-glycoprotein-related efflux carriers: an in-vitro screening.

Deferme S, Van Gelder J, Augustijns P.

J Pharm Pharmacol. 2002 Sep;54(9):1213-9.

PMID:
12356275
25.

Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures.

van Gelder J, Deferme S, Naesens L, De Clercq E, van den Mooter G, Kinget R, Augustijns P.

Drug Metab Dispos. 2002 Aug;30(8):924-30.

PMID:
12124311
26.

Intestinal absorption characteristics of the low solubility thiocarboxanilide UC-781.

Deferme S, Van Gelder J, Ingels F, Van den Mooter G, De Buck S, Balzarini J, Naesens L, De Clercq E, Kinget R, Augustijns P.

Int J Pharm. 2002 Mar 2;234(1-2):113-9.

PMID:
11839442
27.

Mode of administration-dependent pharmacokinetics of bisphosphonates and bioavailability determination.

Hoffman A, Stepensky D, Ezra A, Van Gelder JM, Golomb G.

Int J Pharm. 2001 Jun 4;220(1-2):1-11.

PMID:
11376962
28.

Increased absorption of the antiviral ester prodrug tenofovir disoproxil in rat ileum by inhibiting its intestinal metabolism.

Van Gelder J, Deferme S, Annaert P, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P.

Drug Metab Dispos. 2000 Dec;28(12):1394-6.

PMID:
11095573
29.

Species-dependent and site-specific intestinal metabolism of ester prodrugs.

Van Gelder J, Shafiee M, De Clercq E, Penninckx F, Van den Mooter G, Kinget R, Augustijns P.

Int J Pharm. 2000 Sep 15;205(1-2):93-100.

PMID:
11000545
30.

In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil.

Annaert P, Tukker JJ, van Gelder J, Naesens L, de Clercq E, van Den Mooter G, Kinget R, Augustijns P.

J Pharm Sci. 2000 Aug;89(8):1054-62.

PMID:
10906729
31.

Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA.

Van Gelder J, Witvrouw M, Pannecouque C, Henson G, Bridger G, Naesens L, De Clercq E, Annaert P, Shafiee M, Van den Mooter G, Kinget R, Augustijns P.

Int J Pharm. 1999 Sep 20;186(2):127-36.

PMID:
10486430
32.

Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study.

Van Gelder J, Annaert P, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P.

Pharm Res. 1999 Jul;16(7):1035-40.

PMID:
10450927
33.

Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.

Annaert P, Van Gelder J, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P.

Pharm Res. 1998 Aug;15(8):1168-73.

PMID:
9706045
34.

Learning cardiopulmonary resuscitation skills: does the type of mannequin make a difference?

Noordergraaf GJ, Van Gelder JM, Van Kesteren RG, Diets RF, Savelkoul TJ.

Eur J Emerg Med. 1997 Dec;4(4):204-9.

PMID:
9444504
35.

The neurosurgery workforce in Australia and New Zealand: a report.

van Gelder JM.

J Clin Neurosci. 1997 Apr;4(2):271-2. No abstract available.

PMID:
18638972
36.

In vitro and in vivo effects of tetrakisphosphonates on bone resorption, tumor osteolysis, ectopic calcification, and macrophages.

Van Gelder JM, Breuer E, Schlossman A, Ornoy A, Mönkkönen J, Similä J, Klenner T, Stadler H, Krempien B, Patlas N, Golomb G.

J Pharm Sci. 1997 Mar;86(3):283-9.

PMID:
9050794
37.

Colloid determination of fibrin network permeability.

van Gelder JM, Nair CH, Dhall DP.

Blood Coagul Fibrinolysis. 1996 Nov;7(8):747-60.

PMID:
9034554
38.
39.

Steady-state hollow electron temperature profiles in the Rijnhuizen Tokamak Project.

Hogeweij GM, Oomens AA, Barth CJ, Beurskens MN, Chu CC, van Gelder JF, Lok J, Lopes Cardozo NJ, Pijper FJ, Polman RW, Rommers JH.

Phys Rev Lett. 1996 Jan 22;76(4):632-635. No abstract available.

PMID:
10061508
40.

Substance P and ciliary beat of human upper respiratory cilia in vitro.

Schuil PJ, Ten Berge M, Van Gelder JM, Graamans K, Huizing EH.

Ann Otol Rhinol Laryngol. 1995 Oct;104(10 Pt 1):798-802.

PMID:
7574258
41.

Surgical bleeding and calcium antagonists. Other causes for increased risk of bleeding are possible.

Dorsch N, Van Gelder J.

BMJ. 1995 Aug 5;311(7001):388; author reply 389. No abstract available.

42.

The permeability of fibrin network developed in human plasma.

van Gelder JM, Nair CH, Dhall DP.

Blood Coagul Fibrinolysis. 1995 Jun;6(4):293-301.

PMID:
7548676
43.

Anticalcification and antiresorption effects of bisacylphosphonates.

Van Gelder JM, Breuer E, Ornoy A, Schlossman A, Patlas N, Golomb G.

Bone. 1995 May;16(5):511-20.

PMID:
7654466
44.

Effects of prostaglandins D2 and E2 on ciliary beat frequency of human upper respiratory cilia in vitro.

Schuil PJ, Ten Berge M, Van Gelder JM, Graamans K, Huizing EH.

Acta Otolaryngol. 1995 May;115(3):438-42.

PMID:
7653268
45.

Cool perfusion solutions for skin flaps: a new mixture of pharmacological agents which improves skin flap viability.

Kohout M, Lepore DA, Knight KR, Van Gelder J, O'Brien BM, Stewart AG, Morrison WA.

Br J Plast Surg. 1995 Apr;48(3):132-44.

PMID:
7735675
46.

The significance of red cell surface area to the permeability of fibrin network.

van Gelder JM, Nair CH, Dhall DP.

Biorheology. 1994 May-Jun;31(3):259-75.

PMID:
8729486
47.

Histamine and leukotriene C4 effects on in vitro ciliary beat frequency of human upper respiratory cilia.

Schuil PJ, van Gelder JM, ten Berge M, Graamans K, Huizing EH.

Eur Arch Otorhinolaryngol. 1994;251(6):325-8.

PMID:
7848641
48.

Platelets and the permeability of fibrin network developed in human plasma.

van Gelder JM, Nair CH, Dhall DP.

Thromb Res. 1993 Nov 15;72(4):339-45. No abstract available.

PMID:
8303674
49.

Effects of Poloxamer 188 on fibrin network structure, whole blood clot premeability and fibrinolysis.

van Gelder JM, Nair CH, Dhall DP.

Thromb Res. 1993 Sep 1;71(5):361-76.

PMID:
8236163
50.

In vitro and in vivo anticalcification effects of novel bishydroxyiminophosphonates.

Golomb G, Schlossman A, Eitan Y, Saadeh H, Van Gelder JM, Breuer E.

J Pharm Sci. 1992 Oct;81(10):1004-7.

PMID:
1432609

Supplemental Content

Loading ...
Support Center